Normal AML with the BCR-ABL1 fusion gene is a rare entity, accounting for approximately 1% of all AML subtypes [39], and is often challenging to distinguish from the first presentation of CML in blastic crisis [40,41]. This evidence concerns the gene BCR and acute myeloid leukemia.